Minnesota’s New Cannabis Bill Reshapes Market For Medical And Rec Operators

Minnesota has created a fully integrated cannabis market. A set of reforms to the state’s regulated cannabis market effectively merged its separate medical and adult-use cannabis supply chains.

Governor Tim Walz signed into law the 2026 Omnibus Cannabis Bill on Tuesday. The policy change slashes operating costs and improves margins for vertically integrated operators.

How? With the new measure from Representative Jessica Hanson now in effect, cannabis operators no longer need separate cultivation systems, manufacturing operations, duplicate inventory tracking, or parallel compliance infrastructure.

Besides this most obvious change, new regulations are making medical marijuana a strategic advantage, as businesses are to benefit from maintaining medical endorsements. Some of the benefits include larger canopy allowances, more retail locations, expanded transport authority and delivery rights, to name a few.

Under the new law, macrobusiness licenses are capped at 8 statewide before 2030. These license holders are expected to control the state’s largest cultivation footprints, operate the most extensive retail networks, serve as required participants in the medical market, and emerge as the state’s long-term anchor operators, according to Foley Hoag’s Michael McQueeny and Joshua Rosen.

Some of the cannabis operators that run businesses in Minnesota include Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), an owner of RISE Dispensaries, and Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF), which dispenses both medical and adult-use cannabis products at all of its locations statewide.

The Minnesota Office of Cannabis Management (OCM) is obligated to convert all existing medical cannabis combination business licenses or applications to macrobusiness licenses or applications before January 1, 2027, under the new law.

Furthermore, the new policy change gave hemp businesses a transition path into regulated cannabis as federal THC restrictions arrive this November. The ability to dual-license allows hemp businesses to move into the recreational cannabis market, while transitioning operations gradually and perceiving branding and distribution relationships effectively diversifying revenue prior to the federal ban taking effect.

Simultaneously, the new law is an initial step toward establishing a psilocybin therapeutic-use program in the North Star State. The law directs OCM to publish and deliver a report to the state Legislature by Jan. 15, 2027. The report must include recommendations for administering a program for adults aged 21 and older with qualifying medical conditions. The office is obligated to assess the availability of federal funding that could support the program’s development and implementation on a regular basis.